Neuromodulation Techniques in Chronic Cerebral Hypoperfusion: Mechanisms and Therapeutic Advances
CNS Neuroscience & Therapeutics · 2026-08 · 32 (8)
DOI: 10.1002/cns.71089 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 17.08.2026. Verfasst von Chenye Qiao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Rehabilitation Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Cerebrovascular Circulation, Cognitive Dysfunction, Dementia, Vascular, Brain Ischemia. Die Arbeit nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Chronic cerebral hypoperfusion (CCH) is a major hemodynamic substrate of vascular cognitive impairment and vascular dementia, yet effective therapies with multi‐target neuroprotective potential remain limited. CCH triggers a complex pathological cascade characterized by neurovascular dysfunction, white matter injury, neuroinflammation, oxidative stress, and synaptic impairment.
Methods
In this review, we summarize the major pathophysiological mechanisms of CCH and discuss current evidence supporting neuromodulation as a promising therapeutic strategy. We focus primarily on central stimulation modalities, including repetitive transcranial magnetic stimulation, transcranial electrical stimulation, photobiomodulation, and ultrasound‐based neuromodulation, while also addressing selected peripheral physical modulation approaches and emerging multimodal combination strategies.
Results
Available evidence suggests that these interventions may mitigate hypoperfusion‐related brain injury and cognitive impairment by targeting multiple pathophysiological mechanisms, ultimately restoring synaptic plasticity and promoting circuit‐ and network‐level recovery. We further discuss current challenges to clinical translation, including limited deep‐target engagement, insufficient individualized dosing, and the underuse of rhythm‐based biomarkers.
Conclusion
Neuromodulation holds promise as a mechanistically informed and multi‐target neuroprotective strategy for CCH‐related cognitive impairment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Beijing Rehabilitation Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Hujun Wang, Zongjian Liu, Shuyan Qie
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Qiao, C., Li, N., Wang, C., Wang, Y., Li, J., Wang, H., Liu, Z., & Qie, S. (2026). Neuromodulation Techniques in Chronic Cerebral Hypoperfusion: Mechanisms and Therapeutic Advances. CNS Neuroscience & Therapeutics, 32(8). https://doi.org/10.1002/cns.71089
Vancouver
Qiao C, Li N, Wang C, Wang Y, Li J, Wang H, et al. Neuromodulation Techniques in Chronic Cerebral Hypoperfusion: Mechanisms and Therapeutic Advances. CNS Neuroscience & Therapeutics. 2026;32(8). doi:10.1002/cns.71089
BibTeX
@article{Qiao2026,
author = {Qiao, Chenye and Li, Ning and Wang, Congxiao and Wang, Yingpeng and Li, Jinglu and Wang, Hujun and Liu, Zongjian and Qie, Shuyan},
title = {Neuromodulation Techniques in Chronic Cerebral Hypoperfusion: Mechanisms and Therapeutic Advances},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {8},
doi = {10.1002/cns.71089}
}
EUVIMED